Cargando…

Corrigendum to “The Role of (18)F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis”

Detalles Bibliográficos
Autores principales:	Liu, Qiufang, Wang, Chen, Li, Panli, Liu, Jianjun, Huang, Gang, Song, Shaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075583/ https://www.ncbi.nlm.nih.gov/pubmed/27803920 http://dx.doi.org/10.1155/2016/1235429

Ejemplares similares

The Role of (18)F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis
por: Liu, Qiufang, et al.
Publicado: (2016)

(18)F-Deoxyglucose ((18)F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats
por: Li, Panli, et al.
Publicado: (2019)

Optimal (18)F-FDG PET/CT radiomics model development for predicting EGFR mutation status and prognosis in lung adenocarcinoma: a multicentric study
por: Zuo, Yan, et al.
Publicado: (2023)

Multiparametric (18)F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Umutlu, Lale, et al.
Publicado: (2022)

Preoperative (18)F-FDG PET/CT radiomics analysis for predicting HER2 expression and prognosis in gastric cancer
por: Liu, Qiufang, et al.
Publicado: (2023)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and (18)F-FDG PET/CT in breast cancer subtypes
por: Schmitz, Alexander M. Th., et al.
Publicado: (2017)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

(18)F-FDG PET/CT Radiomics for Preoperative Prediction of Lymph Node Metastases and Nodal Staging in Gastric Cancer
por: Liu, Qiufang, et al.
Publicado: (2021)

The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy [Corrigendum]
Publicado: (2019)

Nomogram to Predict Distant Metastasis Probability for Pathological Complete Response Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy [Corrigendum]
Publicado: (2022)

Prediction of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer by using a deep learning model with (18)F-FDG PET/CT
por: Bulut, Gülcan, et al.
Publicado: (2023)

Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Turan, Umit, et al.
Publicado: (2021)

The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023)

(18)F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
por: Simoni, Nicola, et al.
Publicado: (2020)

Early Assessment of Response to Neoadjuvant Chemotherapy with (18)F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
por: Chung, Young Shin, et al.
Publicado: (2020)

Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer
por: Hulikal, Narendra, et al.
Publicado: (2020)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

(18)F‐FDG PET/CT predicts the role of neoadjuvant immunochemotherapy in the pathological response of esophageal squamous cell carcinoma
por: Wang, Shuohua, et al.
Publicado: (2023)

Corrigendum to “Value of Fused (18)F-Choline-PET/MRI to Evaluate Prostate Cancer Relapse in Patients Showing Biochemical Recurrence after EBRT: Preliminary Results”
por: Piccardo, Arnoldo, et al.
Publicado: (2016)

The feasibility of (18)F-FDG PET/CT for predicting pathologic risk status in early-stage uterine cervical squamous cancer
por: Liu, Shuai, et al.
Publicado: (2020)

Corrigendum to: Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study
por: Fatayer, Hiba, et al.
Publicado: (2022)

Utility of (18)F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
por: Lee, In Hee, et al.
Publicado: (2020)

Prognostic significance of (18)FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysis
por: Xia, Qian, et al.
Publicado: (2015)

The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
por: Palmerini, Emanuela, et al.
Publicado: (2016)

Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and (18)F-FDG PET/CT
por: You, S, et al.
Publicado: (2015)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
por: Allahqoli, Leila, et al.
Publicado: (2023)

Delayed (18)F-FDG PET/CT Appearance of Urachal Adenocarcinomas
por: Xu, Lian, et al.
Publicado: (2020)

The Value of (18)F-FDG PET/CT Imaging in the Evaluation of Interim Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer
por: Tatar, Gamze, et al.
Publicado: (2022)

Baseline 18F-FDG PET/CT as predictor of the pathological response to neoadjuvant therapy in esophageal cancer: A retrospective study
por: Domachevsky, Liran, et al.
Publicado: (2018)

The Relationship between Pathological Features and (18) F-FDG PET/CT that Changed the Surgeon's Decision as Neoadjuvant Therapy in Breast Cancer
por: Edizsoy, Akay, et al.
Publicado: (2022)

CT, MRI, and (18)F-FDG PET/CT imaging features of seven cases of adult pancreatoblastoma
por: Wu, Mengnan, et al.
Publicado: (2022)

Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
por: Chen, Lihua, et al.
Publicado: (2017)

Comparison of MRI vs. [(18)F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives
por: Caracciolo, Matteo, et al.
Publicado: (2023)

Appearance of CNS histoplasmosis on (18)F-FDG PET/CT with MRI correlation
por: Makis, William, et al.
Publicado: (2016)

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
por: Capelli, Giulia, et al.
Publicado: (2022)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation
por: Hagenimana, N., et al.
Publicado: (2017)

Corrigendum to “CLIPPERS: Multiparametric and quantitative MRI features” [Radiology Case Reports 18 (2023) 368–376]
por: Korostyshevskaya, Alexandra M., et al.
Publicado: (2022)

The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Tiberio, Paola, et al.
Publicado: (2023)

Development and External Validation of (18)F-FDG PET-Based Radiomic Model for Predicting Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer
por: Lim, Chae Hong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ctkcs4ktbcpvlg7nalgg1jdve2